{"id":4856,"date":"2025-09-03T15:05:31","date_gmt":"2025-09-03T15:05:31","guid":{"rendered":"https:\/\/freeseandgoss.com\/?page_id=4856"},"modified":"2026-04-06T14:52:08","modified_gmt":"2026-04-06T14:52:08","slug":"demandas-por-dupixent","status":"publish","type":"page","link":"https:\/\/freeseandgoss.com\/es\/masstorts-practice-areas\/dupixent-lawsuits\/","title":{"rendered":"Demanda colectiva contra Dupixent: Efectos secundarios del linfoma de c\u00e9lulas T"},"content":{"rendered":"\n\t\t<div id=\"fws_69e5d8f458690\"  data-column-margin=\"default\" data-midnight=\"dark\"  class=\"wpb_row vc_row-fluid vc_row full-width-section inner-banner top_padding_tablet_100px top_padding_phone_90px bottom_padding_tablet_100px bottom_padding_phone_70px\"  style=\"padding-top: 150px; padding-bottom: 150px; \"><div class=\"row-bg-wrap\" data-bg-animation=\"none\" data-bg-animation-delay=\"\" data-bg-overlay=\"false\"><div class=\"inner-wrap row-bg-layer using-image\" ><div class=\"row-bg viewport-desktop using-image using-bg-color\"  style=\"background-image: url(https:\/\/freeseandgoss.com\/wp-content\/uploads\/2024\/05\/inner-banner1.jpg); background-position: center center; background-repeat: no-repeat; background-color: #010101; \"><\/div><\/div><\/div><div class=\"row_col_wrap_12 col span_12 dark left\">\n\t<div  class=\"vc_col-sm-12 wpb_column column_container vc_column_container col no-extra-padding inherit_tablet inherit_phone \"  data-padding-pos=\"all\" data-has-bg-color=\"false\" data-bg-color=\"\" data-bg-opacity=\"1\" data-animation=\"\" data-delay=\"0\" >\n\t\t<div class=\"vc_column-inner\" >\n\t\t\t<div class=\"wpb_wrapper\">\n\t\t\t\t<h1 style=\"color: #ffffff;line-height: 1.2;text-align: center\" class=\"vc_custom_heading wpb_animate_when_almost_visible wpb_fadeInDown fadeInDown\" >Dupixent Class Action Lawsuit:<br \/>\nT-Cell Lymphoma Side Effects<\/h1>\n\t\t\t<\/div> \n\t\t<\/div>\n\t<\/div> \n<\/div><\/div>\n\t\t<div id=\"fws_69e5d8f458f6d\"  data-column-margin=\"40px\" data-midnight=\"dark\"  class=\"wpb_row vc_row-fluid vc_row full-width-section mobile-text-center reverse_columns_column_tablet top_padding_tablet_30px\"  style=\"padding-top: 50px; padding-bottom: 20px; \"><div class=\"row-bg-wrap\" data-bg-animation=\"none\" data-bg-animation-delay=\"\" data-bg-overlay=\"false\"><div class=\"inner-wrap row-bg-layer\" ><div class=\"row-bg viewport-desktop\"  style=\"\"><\/div><\/div><\/div><div class=\"row_col_wrap_12 col span_12 dark left\">\n\t<div  class=\"vc_col-sm-8 wpb_column column_container vc_column_container col no-extra-padding inherit_tablet inherit_phone \"  data-padding-pos=\"all\" data-has-bg-color=\"false\" data-bg-color=\"\" data-bg-opacity=\"1\" data-animation=\"\" data-delay=\"0\" >\n\t\t<div class=\"vc_column-inner\" >\n\t\t\t<div class=\"wpb_wrapper\">\n\t\t\t\t\n<div class=\"wpb_text_column wpb_content_element  wpb_animate_when_almost_visible wpb_fadeInUp fadeInUp vc_custom_1775487365380\" >\n\t<div class=\"wpb_wrapper\">\n\t\t<p><span style=\"font-weight: 400;\">For many dealing with chronic and painful conditions like eczema or nasal polyps, finding the right medication that brings relief feels like a miracle. When Dupixent (dupilumab) became available, it offered real hope for patients who had long struggled to find something that actually worked.<\/span><\/p>\n<p><span style=\"font-weight: 400;\"><img loading=\"lazy\" decoding=\"async\" class=\" wp-image-4911 alignleft\" src=\"http:\/\/freeseandgoss.com\/wp-content\/uploads\/2025\/09\/The-Nationl-Top-100-Trial-Laywes-300x300.webp\" alt=\"The National Trial Lawyers Top 100\" width=\"120\" height=\"120\" srcset=\"https:\/\/freeseandgoss.com\/wp-content\/uploads\/2025\/09\/The-Nationl-Top-100-Trial-Laywes-300x300.webp 300w, https:\/\/freeseandgoss.com\/wp-content\/uploads\/2025\/09\/The-Nationl-Top-100-Trial-Laywes-150x150.webp 150w, https:\/\/freeseandgoss.com\/wp-content\/uploads\/2025\/09\/The-Nationl-Top-100-Trial-Laywes-768x770.webp 768w, https:\/\/freeseandgoss.com\/wp-content\/uploads\/2025\/09\/The-Nationl-Top-100-Trial-Laywes-12x12.webp 12w, https:\/\/freeseandgoss.com\/wp-content\/uploads\/2025\/09\/The-Nationl-Top-100-Trial-Laywes-140x140.webp 140w, https:\/\/freeseandgoss.com\/wp-content\/uploads\/2025\/09\/The-Nationl-Top-100-Trial-Laywes-100x100.webp 100w, https:\/\/freeseandgoss.com\/wp-content\/uploads\/2025\/09\/The-Nationl-Top-100-Trial-Laywes-500x500.webp 500w, https:\/\/freeseandgoss.com\/wp-content\/uploads\/2025\/09\/The-Nationl-Top-100-Trial-Laywes-350x350.webp 350w, https:\/\/freeseandgoss.com\/wp-content\/uploads\/2025\/09\/The-Nationl-Top-100-Trial-Laywes-1000x1000.webp 1000w, https:\/\/freeseandgoss.com\/wp-content\/uploads\/2025\/09\/The-Nationl-Top-100-Trial-Laywes-800x800.webp 800w, https:\/\/freeseandgoss.com\/wp-content\/uploads\/2025\/09\/The-Nationl-Top-100-Trial-Laywes.webp 1021w\" sizes=\"auto, (max-width: 120px) 100vw, 120px\" \/>This injectable drug has offered a new sense of comfort to countless individuals. However, for some, the relief has been tragically overshadowed by a devastating diagnosis: T-cell lymphoma, a serious form of cancer.<\/span><\/p>\n<p><span style=\"font-weight: 400;\">At Freese &amp; Goss, we understand how devastating a cancer diagnosis can be, especially when it may be connected to a drug you trusted. The idea of taking legal action might feel out of reach right now, but we take pride in making the legal process as clear and manageable as possible.<\/span><\/p>\n<p><span style=\"font-weight: 400;\">With over <\/span><b>$1 billion in <\/b><a href=\"https:\/\/freeseandgoss.com\/verdicts-settlements\/\"><b>settlements and verdicts<\/b><\/a><span style=\"font-weight: 400;\"> and <\/span><b>77 years of combined experience<\/b><span style=\"font-weight: 400;\">, we\u2019ve helped people just like you hold powerful companies accountable.<\/span><\/p>\n<p><span style=\"font-weight: 400;\">If you believe your T-cell lymphoma diagnosis may be linked to Dupixent, reach out today <\/span><a href=\"https:\/\/freeseandgoss.com\/contact-us\/\"><span style=\"font-weight: 400;\">online<\/span><\/a><span style=\"font-weight: 400;\"> or by calling <a href=\"tel:214-761-6623\">214-761-6623<\/a>. Your consultation is free, confidential, and comes with zero obligation<\/span><b>.<\/b><span style=\"font-weight: 400;\">\u00a0<\/span><\/p>\n<blockquote><p>\n<b><i>\u201cThey handled everything professionally, and even in a hard spot, they were able to help me. This is your winning team; they won\u2019t let you down.\u201d<\/i><\/b><\/p>\n<p><span style=\"font-weight: 400;\">&#8211; Daniel U. | Client<\/span>\n<\/p><\/blockquote>\n<h2><span style=\"font-weight: 400;\">What Is Dupixent?<\/span><\/h2>\n<p><span style=\"font-weight: 400;\">Dupixent, also known by its generic name dupilumab, is a biologic drug that hit the market in 2017. Biologic drugs are types of medication made from living organisms. Unlike traditional <\/span><a href=\"https:\/\/freeseandgoss.com\/injured-by-a-medical-device\/\"><span style=\"font-weight: 400;\">drugs<\/span><\/a><span style=\"font-weight: 400;\"> that work on the whole body, biologics are designed to target specific parts of the immune system.\u00a0<\/span><\/p>\n<p><span style=\"font-weight: 400;\">Dupixent works by blocking two proteins, IL-4 and IL-13, that are involved in the inflammation that causes the symptoms of:\u00a0<\/span><\/p>\n<ul>\n<li style=\"font-weight: 400;\" aria-level=\"1\"><span style=\"font-weight: 400;\">Moderate-to-severe eczema (atopic dermatitis)<\/span><\/li>\n<li style=\"font-weight: 400;\" aria-level=\"1\"><span style=\"font-weight: 400;\">Asthma<\/span><\/li>\n<li style=\"font-weight: 400;\" aria-level=\"1\"><span style=\"font-weight: 400;\">Chronic sinusitis with nasal polyps<\/span><\/li>\n<li style=\"font-weight: 400;\" aria-level=\"1\"><span style=\"font-weight: 400;\">Eosinophilic esophagitis<\/span><\/li>\n<\/ul>\n<p><span style=\"font-weight: 400;\">While many people experience significant relief from their symptoms, the drug is not without side effects. The manufacturers of Dupixent, Sanofi and Regeneron, did warn patients of effects, such as:\u00a0<\/span><\/p>\n<ul>\n<li style=\"font-weight: 400;\" aria-level=\"1\"><span style=\"font-weight: 400;\">Injection site reactions<\/span><\/li>\n<li style=\"font-weight: 400;\" aria-level=\"1\"><span style=\"font-weight: 400;\">Eye problems (such as conjunctivitis)<\/span><\/li>\n<li style=\"font-weight: 400;\" aria-level=\"1\"><span style=\"font-weight: 400;\">Oral herpes<\/span><\/li>\n<\/ul>\n<p><span style=\"font-weight: 400;\">However, what patients and doctors were not warned about was the potential for a serious, life-threatening risk of the development or worsening of T-cell lymphoma.<\/span><\/p>\n<h2><span style=\"font-weight: 400;\">Why Are People Filing a Dupixent Lawsuit?<\/span><\/h2>\n<p><span style=\"font-weight: 400;\">When a pharmaceutical company fails to warn the public about a dangerous side effect, it can be held legally responsible for the harm it causes. Studies published in 2024 and 2025 show that people taking Dupixent may face a <\/span><b>300% higher risk<\/b><span style=\"font-weight: 400;\"> of developing cutaneous T-cell lymphoma (CTCL), a rare but aggressive form of non-Hodgkin lymphoma.<\/span><\/p>\n<p><span style=\"font-weight: 400;\">Despite this alarming risk, the drug\u2019s manufacturers, Sanofi and Regeneron, did not warn doctors or patients. This failure to disclose a potentially life-threatening side effect has left many families blindsided by a devastating cancer diagnosis.<\/span><\/p>\n<p><span style=\"font-weight: 400;\">The lawsuits against Sanofi and Regeneron are based on several serious claims:<\/span><\/p>\n<ul>\n<li style=\"font-weight: 400;\" aria-level=\"1\"><span style=\"font-weight: 400;\">Sanofi and Regeneron marketed Dupixent without properly warning patients or healthcare providers about the risk of developing cutaneous T-cell lymphoma.<\/span><\/li>\n<li style=\"font-weight: 400;\" aria-level=\"1\"><span style=\"font-weight: 400;\">CTCL often presents with symptoms that resemble eczema, the very condition Dupixent is prescribed to treat. Without proper warnings, patients and doctors were unable to distinguish between typical eczema flares and signs of something much more serious, delaying diagnosis and treatment.<\/span><\/li>\n<li style=\"font-weight: 400;\" aria-level=\"1\"><span style=\"font-weight: 400;\">Lawsuits claim the manufacturers either knew, or should have known, about the connection between Dupixent and T-cell lymphoma during clinical trials or after the drug entered the market.<\/span><\/li>\n<\/ul>\n<blockquote><p>\n<span style=\"font-weight: 400;\">When early signs of T-cell lymphoma are mistaken for eczema, precious time is lost. What could have been caught and treated earlier may instead progress into something far more serious. For many patients, the realization comes too late.<\/span><\/p>\n<p><span style=\"font-weight: 400;\">At Freese &amp; Goss, we are committed to uncovering the truth and holding drug manufacturers accountable for their failure to warn. Contact us today for a free, confidential case review <\/span><a href=\"https:\/\/freeseandgoss.com\/contact-us\/\"><span style=\"font-weight: 400;\">online<\/span><\/a><span style=\"font-weight: 400;\"> or by calling <a href=\"tel:214-761-6623\">214-761-6623<\/a>.<\/span>\n<\/p><\/blockquote>\n<h2><span style=\"font-weight: 400;\">Research Behind Dupixent and Cancer Claims<\/span><\/h2>\n<p><span style=\"font-weight: 400;\">Several well-respected studies published in 2024 and 2025 have found a significantly increased risk of T-cell lymphoma in patients treated with Dupixent, particularly those with eczema and asthma.<\/span><\/p>\n<p><span style=\"font-weight: 400;\">Here\u2019s what the research shows:<\/span><\/p>\n<h3><span style=\"font-weight: 400;\">Study April 2024<\/span><\/h3>\n<p><span style=\"font-weight: 400;\">This <\/span><a href=\"https:\/\/pubmed.ncbi.nlm.nih.gov\/38588818\/\" target=\"_blank\" rel=\"noopener\"><span style=\"font-weight: 400;\">study<\/span><\/a><span style=\"font-weight: 400;\"> looked at whether people with eczema who were treated with Dupixent had a higher risk of developing CTCL than those who didn\u2019t take the drug.<\/span><\/p>\n<ul>\n<li style=\"font-weight: 400;\" aria-level=\"1\"><span style=\"font-weight: 400;\">In the first analysis, Dupixent users were<\/span><b> over 4 times more likely<\/b><span style=\"font-weight: 400;\"> to develop CTCL.<\/span><\/li>\n<li style=\"font-weight: 400;\" aria-level=\"1\"><span style=\"font-weight: 400;\">Even after accounting for factors like sex, race, and other medications, the risk remained <\/span><b>more than double.<\/b><\/li>\n<li style=\"font-weight: 400;\" aria-level=\"1\"><span style=\"font-weight: 400;\">The researchers concluded that <\/span><b>Dupixent may significantly raise the risk<\/b><span style=\"font-weight: 400;\"> of this rare cancer in certain patients.<\/span><\/li>\n<\/ul>\n<h3><span style=\"font-weight: 400;\">Study August 2024<\/span><\/h3>\n<p><span style=\"font-weight: 400;\">A <\/span><a href=\"https:\/\/onlinelibrary.wiley.com\/doi\/10.1155\/2024\/9924306\" target=\"_blank\" rel=\"noopener\"><span style=\"font-weight: 400;\">second study<\/span><\/a><span style=\"font-weight: 400;\"> using TriNetX health data further supported these findings.<\/span><\/p>\n<ul>\n<li style=\"font-weight: 400;\" aria-level=\"1\"><span style=\"font-weight: 400;\">Patients with eczema who were treated with Dupixent had a <\/span><b>350% higher risk<\/b><span style=\"font-weight: 400;\"> of developing CTCL compared to matched patients who did not take the drug.<\/span><\/li>\n<li style=\"font-weight: 400;\" aria-level=\"1\"><span style=\"font-weight: 400;\">This study excluded patients with other inflammatory conditions or those using other biologics that might have skewed the results, strengthening the link between Dupixent and CTCL.<\/span><\/li>\n<\/ul>\n<h3><span style=\"font-weight: 400;\">Study June 2025<\/span><\/h3>\n<p><span style=\"font-weight: 400;\">In this <\/span><a href=\"https:\/\/pubmed.ncbi.nlm.nih.gov\/40537179\/\" target=\"_blank\" rel=\"noopener\"><span style=\"font-weight: 400;\">more recent study<\/span><\/a><span style=\"font-weight: 400;\">, researchers focused on asthma patients, not eczema, and still found disturbing results.<\/span><\/p>\n<ul>\n<li style=\"font-weight: 400;\" aria-level=\"1\"><span style=\"font-weight: 400;\">Compared to patients using traditional asthma therapies (ICS\/LABA), those treated with Dupixent had a <\/span><b>4.5 times greater risk<\/b><span style=\"font-weight: 400;\"> of developing CTCL.<\/span><\/li>\n<li style=\"font-weight: 400;\" aria-level=\"1\"><span style=\"font-weight: 400;\">Dupixent was also associated with an <\/span><b>overall higher risk of all lymphomas<\/b><span style=\"font-weight: 400;\">, not just CTCL.<\/span><\/li>\n<li style=\"font-weight: 400;\" aria-level=\"1\"><span style=\"font-weight: 400;\">In patients who had been on Dupixent for at least 16 weeks, the risk skyrocketed, especially for a broader group of blood cancers known as <\/span><b>mature T and NK cell lymphomas<\/b><span style=\"font-weight: 400;\">, which showed a <\/span><b>14-fold increase<\/b><span style=\"font-weight: 400;\"> in risk.<\/span><\/li>\n<\/ul>\n<p><span style=\"font-weight: 400;\">Dupixent works by changing how your immune system responds. While that can reduce inflammation and help manage chronic conditions, it may also affect how the body detects and controls abnormal or cancerous cells.<\/span><\/p>\n<p><span style=\"font-weight: 400;\">In short, some researchers believe Dupixent could allow certain lymphomas, like CTCL, to develop faster, or stay hidden longer, especially in patients already at risk.<\/span><\/p>\n<blockquote><p>\n<span style=\"font-weight: 400;\">While past results don\u2019t guarantee future outcomes, they reflect that having a lawyer on your side can help you feel more confident in taking on a lawsuit and may improve your chances of recovering meaningful compensation. For example, in a nationwide Martindale-Nolo study, over 90% of people who hired a personal injury lawyer received compensation, compared to just 51% of those who handled their claims on their own.<\/span><\/p>\n<p><span style=\"font-weight: 400;\">At Freese &amp; Goss, we\u2019re not new to these kinds of battles over defective drugs and medical devices. Our firm helped secure a <\/span><b>$33.6 million verdict<\/b><span style=\"font-weight: 400;\"> in a case involving a defective IVC filter and a <\/span><b>$3 million verdict<\/b><span style=\"font-weight: 400;\"> in a lawsuit over the failure to warn about birth defect risks linked to the drug Topamax.<\/span>\n<\/p><\/blockquote>\n<h3><span style=\"font-weight: 400;\">Do I Qualify for a Dupixent Lymphoma Lawsuit?<\/span><\/h3>\n<p><span style=\"font-weight: 400;\">If you or a loved one used Dupixent and were later diagnosed with T-cell lymphoma, you may be entitled to significant compensation. You may qualify for a Dupixent lawsuit if:<\/span><\/p>\n<ul>\n<li style=\"font-weight: 400;\" aria-level=\"1\"><span style=\"font-weight: 400;\">You were administered Dupixent by injection.<\/span><\/li>\n<li style=\"font-weight: 400;\" aria-level=\"1\"><span style=\"font-weight: 400;\">You received injections for at least <strong>30 days<\/strong>.<\/span><\/li>\n<li style=\"font-weight: 400;\" aria-level=\"1\"><span style=\"font-weight: 400;\">Your last injection occurred between 2017 and the present.<\/span><\/li>\n<li style=\"font-weight: 400;\" aria-level=\"1\"><span style=\"font-weight: 400;\">You were diagnosed with T-cell lymphoma, especially CTCL (cutaneous T-cell lymphoma).<\/span><\/li>\n<\/ul>\n<blockquote><p>\n<span style=\"font-weight: 400;\">Even if you&#8217;re not sure you meet all of these criteria, we encourage you to contact us <\/span><a href=\"https:\/\/freeseandgoss.com\/contact-us\/\"><span style=\"font-weight: 400;\">online<\/span><\/a><span style=\"font-weight: 400;\"> or by calling <a href=\"tel:214-761-6623\">214-761-6623<\/a>. Our Dupixent lawsuit <\/span><a href=\"https:\/\/freeseandgoss.com\/dallas-personal-injury-lawyer\/\"><span style=\"font-weight: 400;\">lawyers<\/span><\/a><span style=\"font-weight: 400;\"> will be able to review the specifics of your situation to determine your eligibility.<\/span>\n<\/p><\/blockquote>\n<h2><span style=\"font-weight: 400;\">Why Work With the Dupixent Lawsuit Attorneys at Freese &amp; Goss?<\/span><\/h2>\n<p><span style=\"font-weight: 400;\">Learning you have T-cell lymphoma is devastating. But finding out it may have been caused, or made worse, by a drug you trusted to help you feel better? That is more than just a medical crisis. You should have been warned. You should have had the chance to make informed choices. You deserved the truth.<\/span><\/p>\n<p><span style=\"font-weight: 400;\">At Freese &amp; Goss, we understand you&#8217;re not just dealing with a legal issue. You&#8217;re facing a frightening diagnosis, expensive medical bills, and a future that now looks very different from what you expected.<\/span><\/p>\n<p><span style=\"font-weight: 400;\">We are not just another law firm hoping for a quick settlement. We are a nationally recognized trial firm with <\/span><b>more than $1 billion recovered<\/b><span style=\"font-weight: 400;\"> for clients and <\/span><b>77 years of combined experience<\/b><span style=\"font-weight: 400;\"> in personal injury and <\/span><a href=\"https:\/\/freeseandgoss.com\/masstorts-practice-areas\/\"><span style=\"font-weight: 400;\">mass tort<\/span><\/a><span style=\"font-weight: 400;\"> litigation. Our team has been chosen for leadership roles in major national lawsuits because we build strong cases and deliver real results.<\/span><\/p>\n<p><span style=\"font-weight: 400;\">If you or someone you love developed cutaneous T-cell lymphoma (CTCL) after using Dupixent, you may be eligible for financial compensation in a Dupixent class action lawsuit. Reach out to Freese &amp; Goss today for a 100% free case review <\/span><a href=\"https:\/\/freeseandgoss.com\/contact-us\/\"><span style=\"font-weight: 400;\">online<\/span><\/a><span style=\"font-weight: 400;\"> or by calling <a href=\"tel:214-761-6623\">214-761-6623<\/a>.<\/span><\/p>\n<h2><span style=\"font-weight: 400;\">Dupixent Lawsuit FAQs<\/span><\/h2>\n\t<\/div>\n<\/div>\n\n\n\n<div class=\"toggles accordion\" data-br=\"\" data-starting=\"default\" data-style=\"minimal\"><div class=\"toggle default\" data-inner-wrap=\"true\"><h3 class=\"toggle-title\"><a href=\"#\" role=\"button\" class=\"toggle-heading\"><i role=\"presentation\" class=\"fa fa-plus-circle\"><\/i>What Kind of Compensation Is Available in a Dupixent Lymphoma Lawsuit?<\/a><\/h3><div><div class=\"inner-toggle-wrap\">\n<div class=\"wpb_text_column wpb_content_element \" >\n\t<div class=\"wpb_wrapper\">\n\t\t<p>If your lawsuit is successful, you may be able to recover compensation for the harm Dupixent has caused. This can include medical bills, both past and ongoing, lost income from time away from work, and the pain, suffering, and emotional toll that comes with a serious illness like T-cell lymphoma.<\/p>\n<p>If you\u2019re pursuing a claim on behalf of a loved one who\u00a0<a href=\"https:\/\/freeseandgoss.com\/dallas-personal-injury-lawyer\/dallas-wrongful-death-lawyer\/\">passed away<\/a>, your family may also be entitled to damages for funeral expenses, loss of companionship, and other related losses.<\/p>\n\t<\/div>\n<\/div>\n\n\n\n<\/div><\/div><\/div><div class=\"toggle default\" data-inner-wrap=\"true\"><h3 class=\"toggle-title\"><a href=\"#\" role=\"button\" class=\"toggle-heading\"><i role=\"presentation\" class=\"fa fa-plus-circle\"><\/i>How Much Does It Cost to Hire the Dupixent Lawsuit Lawyers at Freese &amp; Goss?<\/a><\/h3><div><div class=\"inner-toggle-wrap\">\n<div class=\"wpb_text_column wpb_content_element \" >\n\t<div class=\"wpb_wrapper\">\n\t\t<p>We know that after a serious diagnosis, the last thing you want to worry about is how to afford a lawyer. That\u2019s why we handle Dupixent cases on a contingency fee basis. You pay nothing up front, and there are no out-of-pocket costs to get started. We cover all the expenses of building your case. You only pay us if we win, either through a settlement or a verdict in your favor.<\/p>\n<p>If there\u2019s no recovery, you owe us nothing.<\/p>\n\t<\/div>\n<\/div>\n\n\n\n<\/div><\/div><\/div><div class=\"toggle default\" data-inner-wrap=\"true\"><h3 class=\"toggle-title\"><a href=\"#\" role=\"button\" class=\"toggle-heading\"><i role=\"presentation\" class=\"fa fa-plus-circle\"><\/i>How Do I Prove My T-Cell Lymphoma Is Related to My Dupixent Use?<\/a><\/h3><div><div class=\"inner-toggle-wrap\">\n<div class=\"wpb_text_column wpb_content_element \" >\n\t<div class=\"wpb_wrapper\">\n\t\t<p>Establishing a connection between your diagnosis and Dupixent use involves a careful review of your medical records, treatment timeline, and symptoms. This is where having an experienced legal team can make a real difference.<\/p>\n<p>At Freese &amp; Goss, we work with trusted medical experts who can analyze your case and help determine whether there is a likely link. We gather the right records, consult with specialists, and build a case that is backed by evidence.<\/p>\n\t<\/div>\n<\/div>\n\n\n\n<\/div><\/div><\/div><div class=\"toggle default\" data-inner-wrap=\"true\"><h3 class=\"toggle-title\"><a href=\"#\" role=\"button\" class=\"toggle-heading\"><i role=\"presentation\" class=\"fa fa-plus-circle\"><\/i>What Symptoms Should I Watch for If I or a Loved One Is Using Dupixent?<\/a><\/h3><div><div class=\"inner-toggle-wrap\">\n<div class=\"wpb_text_column wpb_content_element \" >\n\t<div class=\"wpb_wrapper\">\n\t\t<p>If skin symptoms are not getting better with Dupixent, or if the rash starts to look different, becomes more widespread, or gets worse over time, that may be a reason for concern. Some patients have reported persistent itching, the appearance of new lumps or patches, swollen lymph nodes, or unexplained weight loss.<\/p>\n<p>These signs can sometimes be confused with eczema flares, which is why it is important to pay close attention to changes. If symptoms are not improving, ask your doctor about further testing. A skin biopsy or specialist referral may help rule out or confirm something more serious, like cutaneous T-cell lymphoma.<\/p>\n\t<\/div>\n<\/div>\n\n\n\n<\/div><\/div><\/div><\/div>\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\t\t\t<\/div> \n\t\t<\/div>\n\t<\/div> \n\n\t<div style=\"\" class=\"vc_col-sm-4 wpb_column column_container vc_column_container col has-animation border_top_desktop_4px border_color_c81d25 border_style_solid left_padding_desktop_25px left_padding_phone_20px top_padding_desktop_20px top_padding_phone_15px right_padding_desktop_25px right_padding_phone_20px bottom_padding_desktop_25px bottom_padding_phone_20px \" data-using-bg=\"true\" data-padding-pos=\"all\" data-has-bg-color=\"true\" data-bg-color=\"#2c2e7c\" data-bg-opacity=\"1\" data-animation=\"slight-fade-in-from-bottom\" data-delay=\"0\" >\n\t\t<div class=\"vc_column-inner\" ><div class=\"column-bg-overlay-wrap column-bg-layer\" data-bg-animation=\"none\"><div class=\"column-bg-overlay\" style=\"opacity: 1; background-color: #2c2e7c;\"><\/div><\/div>\n\t\t\t<div class=\"wpb_wrapper\">\n\t\t\t\t<h2 style=\"font-size: 24px;color: #ffffff;line-height: 1.2;text-align: center\" class=\"vc_custom_heading\" >Receive a Free Case Review<\/h2>\n<div class=\"wpb_text_column wpb_content_element \" >\n\t<div class=\"wpb_wrapper\">\n\t\t<script type=\"text\/javascript\">\n\/* <![CDATA[ *\/\nvar gform;gform||(document.addEventListener(\"gform_main_scripts_loaded\",function(){gform.scriptsLoaded=!0}),document.addEventListener(\"gform\/theme\/scripts_loaded\",function(){gform.themeScriptsLoaded=!0}),window.addEventListener(\"DOMContentLoaded\",function(){gform.domLoaded=!0}),gform={domLoaded:!1,scriptsLoaded:!1,themeScriptsLoaded:!1,isFormEditor:()=>\"function\"==typeof InitializeEditor,callIfLoaded:function(o){return!(!gform.domLoaded||!gform.scriptsLoaded||!gform.themeScriptsLoaded&&!gform.isFormEditor()||(gform.isFormEditor()&&console.warn(\"The use of gform.initializeOnLoaded() is deprecated in the form editor context and will be removed in Gravity Forms 3.1.\"),o(),0))},initializeOnLoaded:function(o){gform.callIfLoaded(o)||(document.addEventListener(\"gform_main_scripts_loaded\",()=>{gform.scriptsLoaded=!0,gform.callIfLoaded(o)}),document.addEventListener(\"gform\/theme\/scripts_loaded\",()=>{gform.themeScriptsLoaded=!0,gform.callIfLoaded(o)}),window.addEventListener(\"DOMContentLoaded\",()=>{gform.domLoaded=!0,gform.callIfLoaded(o)}))},hooks:{action:{},filter:{}},addAction:function(o,r,e,t){gform.addHook(\"action\",o,r,e,t)},addFilter:function(o,r,e,t){gform.addHook(\"filter\",o,r,e,t)},doAction:function(o){gform.doHook(\"action\",o,arguments)},applyFilters:function(o){return gform.doHook(\"filter\",o,arguments)},removeAction:function(o,r){gform.removeHook(\"action\",o,r)},removeFilter:function(o,r,e){gform.removeHook(\"filter\",o,r,e)},addHook:function(o,r,e,t,n){null==gform.hooks[o][r]&&(gform.hooks[o][r]=[]);var d=gform.hooks[o][r];null==n&&(n=r+\"_\"+d.length),gform.hooks[o][r].push({tag:n,callable:e,priority:t=null==t?10:t})},doHook:function(r,o,e){var t;if(e=Array.prototype.slice.call(e,1),null!=gform.hooks[r][o]&&((o=gform.hooks[r][o]).sort(function(o,r){return o.priority-r.priority}),o.forEach(function(o){\"function\"!=typeof(t=o.callable)&&(t=window[t]),\"action\"==r?t.apply(null,e):e[0]=t.apply(null,e)})),\"filter\"==r)return e[0]},removeHook:function(o,r,t,n){var e;null!=gform.hooks[o][r]&&(e=(e=gform.hooks[o][r]).filter(function(o,r,e){return!!(null!=n&&n!=o.tag||null!=t&&t!=o.priority)}),gform.hooks[o][r]=e)}});\n\/* ]]> *\/\n<\/script>\n\n                <div class='gf_browser_gecko gform_wrapper gform-theme gform-theme--foundation gform-theme--framework gform-theme--orbital hero-page-form_wrapper' data-form-theme='orbital' data-form-index='0' id='gform_wrapper_2' ><style>#gform_wrapper_2[data-form-index=\"0\"].gform-theme,[data-parent-form=\"2_0\"]{--gf-color-primary: #204ce5;--gf-color-primary-rgb: 32, 76, 229;--gf-color-primary-contrast: #fff;--gf-color-primary-contrast-rgb: 255, 255, 255;--gf-color-primary-darker: #001AB3;--gf-color-primary-lighter: #527EFF;--gf-color-secondary: #fff;--gf-color-secondary-rgb: 255, 255, 255;--gf-color-secondary-contrast: #112337;--gf-color-secondary-contrast-rgb: 17, 35, 55;--gf-color-secondary-darker: #F5F5F5;--gf-color-secondary-lighter: #FFFFFF;--gf-color-out-ctrl-light: rgba(17, 35, 55, 0.1);--gf-color-out-ctrl-light-rgb: 17, 35, 55;--gf-color-out-ctrl-light-darker: rgba(104, 110, 119, 0.35);--gf-color-out-ctrl-light-lighter: #F5F5F5;--gf-color-out-ctrl-dark: #585e6a;--gf-color-out-ctrl-dark-rgb: 88, 94, 106;--gf-color-out-ctrl-dark-darker: #112337;--gf-color-out-ctrl-dark-lighter: rgba(17, 35, 55, 0.65);--gf-color-in-ctrl: #fff;--gf-color-in-ctrl-rgb: 255, 255, 255;--gf-color-in-ctrl-contrast: #112337;--gf-color-in-ctrl-contrast-rgb: 17, 35, 55;--gf-color-in-ctrl-darker: #F5F5F5;--gf-color-in-ctrl-lighter: #FFFFFF;--gf-color-in-ctrl-primary: #204ce5;--gf-color-in-ctrl-primary-rgb: 32, 76, 229;--gf-color-in-ctrl-primary-contrast: #fff;--gf-color-in-ctrl-primary-contrast-rgb: 255, 255, 255;--gf-color-in-ctrl-primary-darker: #001AB3;--gf-color-in-ctrl-primary-lighter: #527EFF;--gf-color-in-ctrl-light: rgba(17, 35, 55, 0.1);--gf-color-in-ctrl-light-rgb: 17, 35, 55;--gf-color-in-ctrl-light-darker: rgba(104, 110, 119, 0.35);--gf-color-in-ctrl-light-lighter: #F5F5F5;--gf-color-in-ctrl-dark: #585e6a;--gf-color-in-ctrl-dark-rgb: 88, 94, 106;--gf-color-in-ctrl-dark-darker: #112337;--gf-color-in-ctrl-dark-lighter: rgba(17, 35, 55, 0.65);--gf-radius: 3px;--gf-font-size-secondary: 14px;--gf-font-size-tertiary: 13px;--gf-icon-ctrl-number: url(\"data:image\/svg+xml,%3Csvg width='8' height='14' viewBox='0 0 8 14' fill='none' xmlns='http:\/\/www.w3.org\/2000\/svg'%3E%3Cpath fill-rule='evenodd' clip-rule='evenodd' d='M4 0C4.26522 5.96046e-08 4.51957 0.105357 4.70711 0.292893L7.70711 3.29289C8.09763 3.68342 8.09763 4.31658 7.70711 4.70711C7.31658 5.09763 6.68342 5.09763 6.29289 4.70711L4 2.41421L1.70711 4.70711C1.31658 5.09763 0.683417 5.09763 0.292893 4.70711C-0.0976311 4.31658 -0.097631 3.68342 0.292893 3.29289L3.29289 0.292893C3.48043 0.105357 3.73478 0 4 0ZM0.292893 9.29289C0.683417 8.90237 1.31658 8.90237 1.70711 9.29289L4 11.5858L6.29289 9.29289C6.68342 8.90237 7.31658 8.90237 7.70711 9.29289C8.09763 9.68342 8.09763 10.3166 7.70711 10.7071L4.70711 13.7071C4.31658 14.0976 3.68342 14.0976 3.29289 13.7071L0.292893 10.7071C-0.0976311 10.3166 -0.0976311 9.68342 0.292893 9.29289Z' fill='rgba(17, 35, 55, 0.65)'\/%3E%3C\/svg%3E\");--gf-icon-ctrl-select: url(\"data:image\/svg+xml,%3Csvg width='10' height='6' viewBox='0 0 10 6' fill='none' xmlns='http:\/\/www.w3.org\/2000\/svg'%3E%3Cpath fill-rule='evenodd' clip-rule='evenodd' d='M0.292893 0.292893C0.683417 -0.097631 1.31658 -0.097631 1.70711 0.292893L5 3.58579L8.29289 0.292893C8.68342 -0.0976311 9.31658 -0.0976311 9.70711 0.292893C10.0976 0.683417 10.0976 1.31658 9.70711 1.70711L5.70711 5.70711C5.31658 6.09763 4.68342 6.09763 4.29289 5.70711L0.292893 1.70711C-0.0976311 1.31658 -0.0976311 0.683418 0.292893 0.292893Z' fill='rgba(17, 35, 55, 0.65)'\/%3E%3C\/svg%3E\");--gf-icon-ctrl-search: url(\"data:image\/svg+xml,%3Csvg width='640' height='640' xmlns='http:\/\/www.w3.org\/2000\/svg'%3E%3Cpath d='M256 128c-70.692 0-128 57.308-128 128 0 70.691 57.308 128 128 128 70.691 0 128-57.309 128-128 0-70.692-57.309-128-128-128zM64 256c0-106.039 85.961-192 192-192s192 85.961 192 192c0 41.466-13.146 79.863-35.498 111.248l154.125 154.125c12.496 12.496 12.496 32.758 0 45.254s-32.758 12.496-45.254 0L367.248 412.502C335.862 434.854 297.467 448 256 448c-106.039 0-192-85.962-192-192z' fill='rgba(17, 35, 55, 0.65)'\/%3E%3C\/svg%3E\");--gf-label-space-y-secondary: var(--gf-label-space-y-md-secondary);--gf-ctrl-border-color: #686e77;--gf-ctrl-size: var(--gf-ctrl-size-md);--gf-ctrl-label-color-primary: #112337;--gf-ctrl-label-color-secondary: #112337;--gf-ctrl-choice-size: var(--gf-ctrl-choice-size-md);--gf-ctrl-checkbox-check-size: var(--gf-ctrl-checkbox-check-size-md);--gf-ctrl-radio-check-size: var(--gf-ctrl-radio-check-size-md);--gf-ctrl-btn-font-size: var(--gf-ctrl-btn-font-size-md);--gf-ctrl-btn-padding-x: var(--gf-ctrl-btn-padding-x-md);--gf-ctrl-btn-size: var(--gf-ctrl-btn-size-md);--gf-ctrl-btn-border-color-secondary: #686e77;--gf-ctrl-file-btn-bg-color-hover: #EBEBEB;--gf-field-img-choice-size: var(--gf-field-img-choice-size-md);--gf-field-img-choice-card-space: var(--gf-field-img-choice-card-space-md);--gf-field-img-choice-check-ind-size: var(--gf-field-img-choice-check-ind-size-md);--gf-field-img-choice-check-ind-icon-size: var(--gf-field-img-choice-check-ind-icon-size-md);--gf-field-pg-steps-number-color: rgba(17, 35, 55, 0.8);}<\/style><form method='post' enctype='multipart\/form-data'  id='gform_2' class='hero-page-form' action='\/es\/wp-json\/wp\/v2\/pages\/4856' data-formid='2' novalidate>\n                        <div class='gform-body gform_body'><div id='gform_fields_2' class='gform_fields top_label form_sublabel_below description_below validation_below'><div id=\"field_2_20\" class=\"gfield gfield--type-honeypot gform_validation_container field_sublabel_below gfield--has-description field_description_below field_validation_below gfield_visibility_visible\"  ><label class='gfield_label gform-field-label' for='input_2_20'>Email<\/label><div class='ginput_container'><input name='input_20' id='input_2_20' type='text' value='' autocomplete='new-password'\/><\/div><div class='gfield_description' id='gfield_description_2_20'>This field is for validation purposes and should be left unchanged.<\/div><\/div><div id=\"field_2_1\" class=\"gfield gfield--type-text gfield--input-type-text gfield_contains_required field_sublabel_below gfield--no-description field_description_below field_validation_below gfield_visibility_visible\"  ><label class='gfield_label gform-field-label' for='input_2_1'>First Name<span class=\"gfield_required\"><span class=\"gfield_required gfield_required_text\">(Required)<\/span><\/span><\/label><div class='ginput_container ginput_container_text'><input name='input_1' id='input_2_1' type='text' value='' class='large'    placeholder='First Name *' aria-required=\"true\" aria-invalid=\"false\"   \/><\/div><\/div><div id=\"field_2_10\" class=\"gfield gfield--type-text gfield--input-type-text gfield--width-full gfield_contains_required field_sublabel_below gfield--no-description field_description_below field_validation_below gfield_visibility_visible\"  ><label class='gfield_label gform-field-label' for='input_2_10'>Last Name<span class=\"gfield_required\"><span class=\"gfield_required gfield_required_text\">(Required)<\/span><\/span><\/label><div class='ginput_container ginput_container_text'><input name='input_10' id='input_2_10' type='text' value='' class='large'    placeholder='Last Name *' aria-required=\"true\" aria-invalid=\"false\"   \/><\/div><\/div><div id=\"field_2_3\" class=\"gfield gfield--type-phone gfield--input-type-phone gfield--width-full gfield_contains_required field_sublabel_below gfield--no-description field_description_below field_validation_below gfield_visibility_visible\"  ><label class='gfield_label gform-field-label' for='input_2_3'>Phone Number<span class=\"gfield_required\"><span class=\"gfield_required gfield_required_text\">(Required)<\/span><\/span><\/label><div class='ginput_container ginput_container_phone'><input name='input_3' id='input_2_3' type='tel' value='' class='large'  placeholder='Phone Number *' aria-required=\"true\" aria-invalid=\"false\"   \/><\/div><\/div><div id=\"field_2_4\" class=\"gfield gfield--type-email gfield--input-type-email gfield--width-full gfield_contains_required field_sublabel_below gfield--no-description field_description_below field_validation_below gfield_visibility_visible\"  ><label class='gfield_label gform-field-label' for='input_2_4'>Email Address<span class=\"gfield_required\"><span class=\"gfield_required gfield_required_text\">(Required)<\/span><\/span><\/label><div class='ginput_container ginput_container_email'>\n                            <input name='input_4' id='input_2_4' type='email' value='' class='large'   placeholder='Email Address *' aria-required=\"true\" aria-invalid=\"false\"  \/>\n                        <\/div><\/div><div id=\"field_2_5\" class=\"gfield gfield--type-textarea gfield--input-type-textarea gfield--width-full field_sublabel_below gfield--no-description field_description_below field_validation_below gfield_visibility_visible\"  ><label class='gfield_label gform-field-label' for='input_2_5'>Brief Description of Your Legal Issue<\/label><div class='ginput_container ginput_container_textarea'><textarea name='input_5' id='input_2_5' class='textarea small'    placeholder='Tell us what happened'  aria-invalid=\"false\"   rows='10' cols='50'><\/textarea><\/div><\/div><fieldset id=\"field_2_12\" class=\"gfield gfield--type-checkbox gfield--type-choice gfield--input-type-checkbox gfield--width-full check-box-style field_sublabel_below gfield--no-description field_description_below hidden_label field_validation_below gfield_visibility_visible\"  ><legend class='gfield_label gform-field-label gfield_label_before_complex' >Checkbox<\/legend><div class='ginput_container ginput_container_checkbox'><div class='gfield_checkbox ' id='input_2_12'><div class='gchoice gchoice_2_12_1'>\n\t\t\t\t\t\t\t\t<input class='gfield-choice-input' name='input_12.1' type='checkbox'  value='True'  id='choice_2_12_1'   \/>\n\t\t\t\t\t\t\t\t<label for='choice_2_12_1' id='label_2_12_1' class='gform-field-label gform-field-label--type-inline'>By checking this box, I consent to receive text messages from Freese &amp; Goss, PLLC related to conversational purposes, appointment reminders, follow-up on cases, order confirmations, etc. You may reply STOP to opt out at any time. For assistance, reply HELP. Messages and data rates may apply. Message frequency will vary. Learn more by visiting our <a href=\"https:\/\/freeseandgoss.com\/privacy-policy\/\"> Privacy Policy Page<\/a>.<\/label>\n\t\t\t\t\t\t\t<\/div><\/div><\/div><\/fieldset><fieldset id=\"field_2_13\" class=\"gfield gfield--type-checkbox gfield--type-choice gfield--input-type-checkbox gfield--width-full check-box-style field_sublabel_below gfield--no-description field_description_below hidden_label field_validation_below gfield_visibility_visible\"  ><legend class='gfield_label gform-field-label gfield_label_before_complex' >Checkbox<\/legend><div class='ginput_container ginput_container_checkbox'><div class='gfield_checkbox ' id='input_2_13'><div class='gchoice gchoice_2_13_1'>\n\t\t\t\t\t\t\t\t<input class='gfield-choice-input' name='input_13.1' type='checkbox'  value='True'  id='choice_2_13_1'   \/>\n\t\t\t\t\t\t\t\t<label for='choice_2_13_1' id='label_2_13_1' class='gform-field-label gform-field-label--type-inline'>By checking this box, I consent to receive future emails from Freese &amp; Goss, PLLC about legal news, case updates, or related information.<\/label>\n\t\t\t\t\t\t\t<\/div><\/div><\/div><\/fieldset><div id=\"field_2_6\" class=\"gfield gfield--type-hidden gfield--input-type-hidden gfield--width-full gform_hidden field_sublabel_below gfield--no-description field_description_below field_validation_below gfield_visibility_visible\"  ><div class='ginput_container ginput_container_text'><input name='input_6' id='input_2_6' type='hidden' class='gform_hidden'  aria-invalid=\"false\" value='' \/><\/div><\/div><div id=\"field_2_7\" class=\"gfield gfield--type-hidden gfield--input-type-hidden gform_hidden field_sublabel_below gfield--no-description field_description_below field_validation_below gfield_visibility_visible\"  ><div class='ginput_container ginput_container_text'><input name='input_7' id='input_2_7' type='hidden' class='gform_hidden'  aria-invalid=\"false\" value='' \/><\/div><\/div><div id=\"field_2_8\" class=\"gfield gfield--type-hidden gfield--input-type-hidden gform_hidden field_sublabel_below gfield--no-description field_description_below field_validation_below gfield_visibility_visible\"  ><div class='ginput_container ginput_container_text'><input name='input_8' id='input_2_8' type='hidden' class='gform_hidden'  aria-invalid=\"false\" value='' \/><\/div><\/div><div id=\"field_2_9\" class=\"gfield gfield--type-hidden gfield--input-type-hidden gform_hidden field_sublabel_below gfield--no-description field_description_below field_validation_below gfield_visibility_visible\"  ><div class='ginput_container ginput_container_text'><input name='input_9' id='input_2_9' type='hidden' class='gform_hidden'  aria-invalid=\"false\" value='' \/><\/div><\/div><div id=\"field_2_14\" class=\"gfield gfield--type-hidden gfield--input-type-hidden gfield--width-full gform_hidden field_sublabel_below gfield--no-description field_description_below field_validation_below gfield_visibility_visible\"  ><div class='ginput_container ginput_container_text'><input name='input_14' id='input_2_14' type='hidden' class='gform_hidden'  aria-invalid=\"false\" value='[channel]' \/><\/div><\/div><div id=\"field_2_15\" class=\"gfield gfield--type-hidden gfield--input-type-hidden gfield--width-full gform_hidden field_sublabel_below gfield--no-description field_description_below field_validation_below gfield_visibility_visible\"  ><div class='ginput_container ginput_container_text'><input name='input_15' id='input_2_15' type='hidden' class='gform_hidden'  aria-invalid=\"false\" value='[channeldrilldown1]' \/><\/div><\/div><div id=\"field_2_16\" class=\"gfield gfield--type-hidden gfield--input-type-hidden gfield--width-full gform_hidden field_sublabel_below gfield--no-description field_description_below field_validation_below gfield_visibility_visible\"  ><div class='ginput_container ginput_container_text'><input name='input_16' id='input_2_16' type='hidden' class='gform_hidden'  aria-invalid=\"false\" value='[channeldrilldown2]' \/><\/div><\/div><div id=\"field_2_17\" class=\"gfield gfield--type-hidden gfield--input-type-hidden gfield--width-full gform_hidden field_sublabel_below gfield--no-description field_description_below field_validation_below gfield_visibility_visible\"  ><div class='ginput_container ginput_container_text'><input name='input_17' id='input_2_17' type='hidden' class='gform_hidden'  aria-invalid=\"false\" value='[channeldrilldown3]' \/><\/div><\/div><div id=\"field_2_18\" class=\"gfield gfield--type-hidden gfield--input-type-hidden gfield--width-full gform_hidden field_sublabel_below gfield--no-description field_description_below field_validation_below gfield_visibility_visible\"  ><div class='ginput_container ginput_container_text'><input name='input_18' id='input_2_18' type='hidden' class='gform_hidden'  aria-invalid=\"false\" value='[landingpage]' \/><\/div><\/div><div id=\"field_2_19\" class=\"gfield gfield--type-hidden gfield--input-type-hidden gfield--width-full gform_hidden field_sublabel_below gfield--no-description field_description_below field_validation_below gfield_visibility_visible\"  ><div class='ginput_container ginput_container_text'><input name='input_19' id='input_2_19' type='hidden' class='gform_hidden'  aria-invalid=\"false\" value='[landingpagegroup]' \/><\/div><\/div><\/div><\/div>\n        <div class='gform-footer gform_footer top_label'> <input type='submit' id='gform_submit_button_2' class='gform_button button' onclick='gform.submission.handleButtonClick(this);' data-submission-type='submit' value='Request Consultation'  \/> \n            <input type='hidden' class='gform_hidden' name='gform_submission_method' data-js='gform_submission_method_2' value='postback' \/>\n            <input type='hidden' class='gform_hidden' name='gform_theme' data-js='gform_theme_2' id='gform_theme_2' value='orbital' \/>\n            <input type='hidden' class='gform_hidden' name='gform_style_settings' data-js='gform_style_settings_2' id='gform_style_settings_2' value='[]' \/>\n            <input type='hidden' class='gform_hidden' name='is_submit_2' value='1' \/>\n            <input type='hidden' class='gform_hidden' name='gform_submit' value='2' \/>\n            \n            <input type='hidden' class='gform_hidden' name='gform_currency' data-currency='USD' value='4dB7Kog3C8j5WAyDq+vdITAeOtU4X7IO6b9Yqb88vOxUbYmvIaUvvBdAqEgMVT2z+8LdTjIHgrfp\/OgZC3TXhMVQs5GJU0\/KqdnaNv0hrLcctDk=' \/>\n            <input type='hidden' class='gform_hidden' name='gform_unique_id' value='' \/>\n            <input type='hidden' class='gform_hidden' name='state_2' value='WyJ7XCIxMi4xXCI6XCI1MDQ4NDY5NzAxM2Q5ODkyMzQ4ZmE4Yjg3OTJlODQ5M1wiLFwiMTMuMVwiOlwiNTA0ODQ2OTcwMTNkOTg5MjM0OGZhOGI4NzkyZTg0OTNcIn0iLCJiMGQwNzBkNmQ0N2U4NDM1MTczNWRhMjBhOThhMTY3YiJd' \/>\n            <input type='hidden' autocomplete='off' class='gform_hidden' name='gform_target_page_number_2' id='gform_target_page_number_2' value='0' \/>\n            <input type='hidden' autocomplete='off' class='gform_hidden' name='gform_source_page_number_2' id='gform_source_page_number_2' value='1' \/>\n            <input type='hidden' name='gform_field_values' value='' \/>\n            \n        <\/div>\n                        <\/form>\n                        <\/div><script type=\"text\/javascript\">\n\/* <![CDATA[ *\/\n gform.initializeOnLoaded( function() {gformInitSpinner( 2, 'https:\/\/freeseandgoss.com\/wp-content\/plugins\/gravityforms\/images\/spinner.svg', false );jQuery('#gform_ajax_frame_2').on('load',function(){var contents = jQuery(this).contents().find('*').html();var is_postback = contents.indexOf('GF_AJAX_POSTBACK') >= 0;if(!is_postback){return;}var form_content = jQuery(this).contents().find('#gform_wrapper_2');var is_confirmation = jQuery(this).contents().find('#gform_confirmation_wrapper_2').length > 0;var is_redirect = contents.indexOf('gformRedirect(){') >= 0;var is_form = form_content.length > 0 && ! is_redirect && ! is_confirmation;var mt = parseInt(jQuery('html').css('margin-top'), 10) + parseInt(jQuery('body').css('margin-top'), 10) + 100;if(is_form){jQuery('#gform_wrapper_2').html(form_content.html());if(form_content.hasClass('gform_validation_error')){jQuery('#gform_wrapper_2').addClass('gform_validation_error');} else {jQuery('#gform_wrapper_2').removeClass('gform_validation_error');}setTimeout( function() { \/* delay the scroll by 50 milliseconds to fix a bug in chrome *\/  }, 50 );if(window['gformInitDatepicker']) {gformInitDatepicker();}if(window['gformInitPriceFields']) {gformInitPriceFields();}var current_page = jQuery('#gform_source_page_number_2').val();gformInitSpinner( 2, 'https:\/\/freeseandgoss.com\/wp-content\/plugins\/gravityforms\/images\/spinner.svg', false );jQuery(document).trigger('gform_page_loaded', [2, current_page]);window['gf_submitting_2'] = false;}else if(!is_redirect){var confirmation_content = jQuery(this).contents().find('.GF_AJAX_POSTBACK').html();if(!confirmation_content){confirmation_content = contents;}jQuery('#gform_wrapper_2').replaceWith(confirmation_content);jQuery(document).trigger('gform_confirmation_loaded', [2]);window['gf_submitting_2'] = false;wp.a11y.speak(jQuery('#gform_confirmation_message_2').text());}else{jQuery('#gform_2').append(contents);if(window['gformRedirect']) {gformRedirect();}}jQuery(document).trigger(\"gform_pre_post_render\", [{ formId: \"2\", currentPage: \"current_page\", abort: function() { this.preventDefault(); } }]);        if (event && event.defaultPrevented) {                return;        }        const gformWrapperDiv = document.getElementById( \"gform_wrapper_2\" );        if ( gformWrapperDiv ) {            const visibilitySpan = document.createElement( \"span\" );            visibilitySpan.id = \"gform_visibility_test_2\";            gformWrapperDiv.insertAdjacentElement( \"afterend\", visibilitySpan );        }        const visibilityTestDiv = document.getElementById( \"gform_visibility_test_2\" );        let postRenderFired = false;        function triggerPostRender() {            if ( postRenderFired ) {                return;            }            postRenderFired = true;            gform.core.triggerPostRenderEvents( 2, current_page );            if ( visibilityTestDiv ) {                visibilityTestDiv.parentNode.removeChild( visibilityTestDiv );            }        }        function debounce( func, wait, immediate ) {            var timeout;            return function() {                var context = this, args = arguments;                var later = function() {                    timeout = null;                    if ( !immediate ) func.apply( context, args );                };                var callNow = immediate && !timeout;                clearTimeout( timeout );                timeout = setTimeout( later, wait );                if ( callNow ) func.apply( context, args );            };        }        const debouncedTriggerPostRender = debounce( function() {            triggerPostRender();        }, 200 );        if ( visibilityTestDiv && visibilityTestDiv.offsetParent === null ) {            const observer = new MutationObserver( ( mutations ) => {                mutations.forEach( ( mutation ) => {                    if ( mutation.type === 'attributes' && visibilityTestDiv.offsetParent !== null ) {                        debouncedTriggerPostRender();                        observer.disconnect();                    }                });            });            observer.observe( document.body, {                attributes: true,                childList: false,                subtree: true,                attributeFilter: [ 'style', 'class' ],            });        } else {            triggerPostRender();        }    } );} ); \n\/* ]]> *\/\n<\/script>\n\n\t<\/div>\n<\/div>\n\n\n\n\n\t\t\t<\/div> \n\t\t<\/div>\n\t<\/div> \n<\/div><\/div>\n","protected":false},"excerpt":{"rendered":"Demanda colectiva contra Dupixent: efectos secundarios del linfoma de c\u00e9lulas T Para muchas personas que padecen afecciones cr\u00f3nicas y dolorosas, como el eccema o los p\u00f3lipos nasales, encontrar el medicamento adecuado que les alivie es como...","protected":false},"author":12,"featured_media":0,"parent":81,"menu_order":0,"comment_status":"closed","ping_status":"closed","template":"","meta":{"inline_featured_image":false,"footnotes":""},"class_list":["post-4856","page","type-page","status-publish"],"_links":{"self":[{"href":"https:\/\/freeseandgoss.com\/es\/wp-json\/wp\/v2\/pages\/4856","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/freeseandgoss.com\/es\/wp-json\/wp\/v2\/pages"}],"about":[{"href":"https:\/\/freeseandgoss.com\/es\/wp-json\/wp\/v2\/types\/page"}],"author":[{"embeddable":true,"href":"https:\/\/freeseandgoss.com\/es\/wp-json\/wp\/v2\/users\/12"}],"replies":[{"embeddable":true,"href":"https:\/\/freeseandgoss.com\/es\/wp-json\/wp\/v2\/comments?post=4856"}],"version-history":[{"count":15,"href":"https:\/\/freeseandgoss.com\/es\/wp-json\/wp\/v2\/pages\/4856\/revisions"}],"predecessor-version":[{"id":5701,"href":"https:\/\/freeseandgoss.com\/es\/wp-json\/wp\/v2\/pages\/4856\/revisions\/5701"}],"up":[{"embeddable":true,"href":"https:\/\/freeseandgoss.com\/es\/wp-json\/wp\/v2\/pages\/81"}],"wp:attachment":[{"href":"https:\/\/freeseandgoss.com\/es\/wp-json\/wp\/v2\/media?parent=4856"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}